611
Views
68
CrossRef citations to date
0
Altmetric
Original Article

In Vivo Evaluation of Novel Nanoparticles Containing Dexamethasone for Ocular Drug Delivery on Rabbit Eye

, , , , , & show all
Pages 1081-1089 | Received 16 Dec 2009, Accepted 12 Jul 2010, Published online: 20 Oct 2010

REFERENCES

  • Sanchez A, Alonso MJ. Nanoparticular carriers for ocular drug delivery. In: Torchilin V (Ed.). Nanoparticulates as Drug Carriers. London, UK: World Scientific-Imperial College Press, 2006.
  • Hay DNT, Rickert PG, Seifert S, et al. Thermoresponsive nanostructures by self-assembly of a poly (N isopropylacrylamide)- lipid conjugate. J Am Chem Soc. 2004;126:2290–2291.
  • Kakizawa Y, Kataoka K. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir. 2002;18:4539–4543.
  • Topp MDC, Dijkstra PJ, Talsma H, et al. Thermosensitive micelle-forming block copolymers of poly (ethylene glycol) and poly (N-isopropylacrylamide). Macromolecules. 1997;30:8518–8520.
  • Chaw CS, Chooi KW, Liu XM, et al. Thermally responsive core–shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: Drug incorporation and in vitro release. Biomaterials. 2004;25:4297–4308.
  • Chung JE, Yokoyama M, Okano T. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Control Rel. 2000;65:93–103.
  • Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Delivery Rev. 2008;60:1638–1649.
  • Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Dis Today 2003;8:1112–1120.
  • Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13:144–150.
  • Gupta AK, Madan S, Majumdar DK, et al. Ketorolac entrapped in polymeric micelles: Preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm. 2000;209:1–14.
  • Maitra AN, Gupta AK, Majumdar D, et al. Sustained release and long residing ophthalmic formulation and the process of preparing the same. U.S. Patent 0064513 A1, May 30, 2002.
  • Maitra AN, Gupta AK, Majumdar D, et al. Sustained release and long residing ophthalmic formulation and the process of preparing the same. U.S. Patent 6579519 B2, June 17, 2003.
  • Kassem MA, Abdel Rahman AA, Ghorab MM, et al. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340:126–133.
  • Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39–43.
  • Nagarwal RC, Kant S, Singh PN, et al. Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Rel. 2009;136:2–13.
  • De Jaeghere F, Doelker E, Gurny R. In: Mathiowitz E (Ed). Nanoparticles. Encyclopedia of Controlled Drug Delivery. New York: John Wiley & Sons, Inc.,1999;2:641–664.
  • Veiseh M, Gunn JW, Zhang M. Design and fabrication of magnetic for targeted drug delivery and imaging. 2009; in press.
  • Hogan MJ, Kimura ST, Thygeson P. Signs and symptoms of uveitis. Archives of Ophthalmology. 1959 May; 47(5, Part 2):155–170.
  • Urtti A, Salminen L. Animal pharmacokinetic studies. In: Mitra AK (Ed.). Ophthalmic Drug Delivery Systems. New York: Marcel Dekker, 1993; pp. 121–136.
  • Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm. 2005;60:207–225.
  • Michelle L, Reichle OD. Complications of intravitreal steroid injections. J Am Optom Assoc. 2005; 76: 450–460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.